- Proximity to Discovery (PtD) Secondment Awards - OPEN (responsive mode)
Applications can be submitted any time for consideration.
UCL TRO invites members of the UCL community to apply for funding under the Proximity-to-Discovery award which was granted to the TRO from the MRC. The secondment awards are suitable for UCL researchers looking to promote their engagement in knowledge transfer to companies, social enterprises, charities and other non-academic organisations.
Further information about the scheme and how to apply can be found below.
- PtD award criteria and how to apply
- PtD award flyer
- PtD secondment application form
- For further costing guidance
- The review panel consists of the SLMS Vice Deans of Enterprise.
- List of funded projects - PtD Secondment Awards
- Therapeutic Acceleration Support (TAS) Fund - CLOSED.
The UCL Therapeutic Acceleration Support (TAS) Fund aims to accelerate the transition from discovery science to the early stages of therapeutic development, by providing responsive and flexible funding to overcome specific “hurdle(s)” in translational progression, allowing projects to position themselves to apply for MRC Developmental Pathway Funding Scheme (DPFS) or similar follow-on funding schemes. This award includes a ring-fenced fund of £75,000 to support projects that address the aims of the Global Challenges Research Fund.
Managed by the Translation Research Office, the TAS fund (total of £1.2M) is supported by the MRC Confidence in Concept scheme, Wellcome Trust Institutional Strategic Support Fund and the three NIHR Biomedical Research Centres (BRC) affiliated with UCL (University College London Hospitals NHS Foundation Trust (UCLH) BRC, Great Ormond Street Hospital (GOSH) BRC and Moorfields BRC).
The review panel is populated by internal and external academics, clinicians and professionals who have experience of translation and commercialisation. List of Panel Members.
Prior to preparing an application please contact the Translational Research Office to check that your project is within remit for the scheme: Main points of contact are Dr Joanna Davidge and Dr Simon Eaglestone.
TAS fund Round 2: The second call for applications closed on the 13th October 2017. The 24 project proposals received are currently undergoing review and will be discussed at the selection Panel meeting w/c 4th December. All applicants will be notified of the outcome shortly thereafter.
TAS fund Round 1:
The TAS Fund Panel met on the 3rd July 2017 to consider the 21 project applications received for Round 1 and discuss the feedback provided by a number of expert reviewers, who are not necessarily core members of the selection Panel. The proposals encompassed modalities aligned across all of the Therapeutic Innovation Networks (TIN), with 6 applications within the Cell, Gene & Regenerative Medicine TIN; 2 applications Devices; 1 application Diagnostics & 12 applications Small Molecule TIN. In this inaugural call, 10 individual project proposals were each awarded TAS funding up to £75k (directly incurred costs only) for up to 12 months.
List of funded projects from Round 1 of the TAS Fund.
Each of the 10 awarded projects has been allocated a TRO Translational Research Manager to work alongside the team providing guidance and support to achieve their TAS-funded translational progression. Moreover, all applicant to the scheme will be provided feedback and encouraged to develop their proposal, building upon the comments and advice received from the Panel and reviewers.